ZAVESCA
ZAVESCA
Approved
DIN Number
02250519
Drug Class
Human
Market Date
May 26, 2004
Company
HC
Janssen Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02250519
AIG Number0150021001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A16AX06 MIGLUSTAT
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification92:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
MIGLUSTATActive
Strength: 100 MG
Monograph: MIGLUSTAT